Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The GLP1R gene (particularly the rs6923761 variant) influences how efficiently your GLP-1 receptors function, potentially accelerating or moderating your appetite-suppression timeline
When combined with a recommended diet and exercise plan patient will lower their risk of having a heart attack or stroke in the next 10 years
Boxed warning thyroid C-cell tumors: GLP-1-based medications (including semaglutide, tirzepatide, and orforglipron) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies
The warning is related to the risk of thyroid cancer, specifically medullary thyroid carcinoma
Where researchers do add compounds, they are usually pursuing a different axis entirely for example a GH-axis or metabolic peptide for goals KLOW does not target
The starting dose is 0.25 mg per week
